Home
>
Nutritional Supplements
>
Reviving Vitamin E Studies That Challenge Claims of Wonder Supplement Also Leave Openings

Reviving Vitamin E Studies That Challenge Claims of Wonder Supplement Also Leave Openings

The last year hasn't been a good one for vitamin E.

Once considered a wonder supplement, an inexpensive and harmless pill that might prevent heart disease, cancer and Alzheimer's, a flurry of recent clinical trials suggest it does none of those things.

Some even suggest there is a small chance it could be harmful in higher doses.

Yet while the oily little capsule apparently can't keep people alive longer, it refuses to die, in part because in nearly every one of the recent negative studies some caveat or contradictory finding creates a glimmer of hope.

It also doesn't hurt that the dietary supplement industry continues to promote vitamin E and offers experts to refute some of new research.

"It doesn't go away," said Edgar Miller, a vitamin E researcher and associate professor of medicine at Johns Hopkins University. "Why does it keep selling when there are so many of these negative studies?"

The answer appears to be a combination of factors, including years of promising laboratory, animal and epidemiological studies; heavy promotion by the dietary supplement industry; and, more recently, contradictory findings within studies showing no overall benefit.

The required daily amount is 22 IU (international units). Many recent clinical trials have ranged from 300 IU to 2,000 IU.

Recent clinical trials of high-dose vitamin E have led some researchers to speculate that vitamin E in megadoses may increase the oxidation of LDL cholesterol, the bad kind.

When cholesterol is oxidated, it contributes to coronary artery disease.

There also is some concern that high amounts of vitamin E may displace other beneficial anti-oxidants from that average person's diet.

Combining studies

Consider these recent studies: In November, a vitamin E bombshell was dropped by Johns Hopkins University researchers at an American Heart Association meeting.

They pooled 19 clinical trials of vitamin E involving 136,000 patients.

In 11 of the high-dose trials (400 IU or more), the risk of dying from any cause increased 4%, compared with people taking placebos.

Prior to that finding, vitamin E had been considered, at worst, harmless.

"People take anti-oxidants because they want to live longer," said Miller, an associate professor of medicine. "What we showed is you don't live longer."

However, the analysis also suggested that lower doses of vitamin E (less than 150 I.U. a day) were associated with about a 2% reduction in deaths.

Researchers acknowledged several potential shortcomings in their study.

For instance, they noted that several of the high-dose trials involved people with various chronic diseases and may not apply to healthy individuals.

They also said the small size of several of the trials in the analysis and inconsistent reporting of health events prevented a detailed look at the effect of various doses of the vitamin.

"It's a very flawed analysis," said Julie Buring, a professor of medicine at Harvard Medical School who recently presented her own vitamin E research.

She also said the 4% increased risk of death was not "clinically meaningful" and could be a chance finding.

Women's health study

On March 7, Buring and other Harvard scientists presented their own vitamin E study at the American College of Cardiology annual meeting.

Once again, the vitamin threw researchers a curve.

Analyzing data from the Women's Health Study, a trial involving 40,000 women who got either 600 IU of vitamin E every other day or a placebo, researchers found that it provided no overall cardiovascular benefit such as reduction in heart attacks or strokes.

However, an analysis of a subgroup of women over 65 found a 26% reduction in cardiovascular events.

Buring said that although the finding was "intriguing," it was not supported by previous research.

She added that it needs confirmation.

Adding even more confusion, the study found a statistically significant 24% reduction in cardiovascular deaths among all the vitamin E users.

Buring also questioned that finding because there was no overall reduction in strokes and heart attacks. She said it was possible that it was due to other cardiovascular causes such as arrhythmias or heart failure, but there was no reasonable biological explanation for that.

"People should look at that further, but it could be chance," she said.

Buring concluded that vitamin E was neither harmful nor beneficial in preventing cardiovascular disease.

A surprise

About a week after the Women's Health Study, another controversial vitamin E finding was presented.

The study involved 9,500 people aged 55 and older with vascular disease or diabetes who were followed for an average of seven years.

It found that 400 IU of vitamin E a day provided no protection against cancer or major vascular events such as heart attacks or strokes.

In addition, the study found a disturbing 13% increase in heart failure cases and 21% increase in heart failure hospitalizations.

That was the first time that vitamin E had been associated with an increased risk of heart failure, said lead author Eva Lonn, a professor of medicine at McMaster University in Hamilton, Ontario.

"I am not convinced about the harm," Lonn added.

Indeed, a recent small study of heart failure patients taking a cholesterol-lowering statin drug suggested that vitamin E actually increased the statin's ability to improve blood vessel function and lower inflammation.

Lonn and the other researchers said a review of all heart failure events in large vitamin E clinical trials "is strongly recommended."

Confounding the heart failure finding was what appeared to be a statistically significant 28% reduction in lung cancer cases, although in a secondary analysis of the data the benefit seemed to disappear.

"The numbers are small," Lonn said. "We think it's a chance finding."

The researchers noted that other larger vitamin E trials showed no lung cancer benefit.

Alzheimer's research

There still is some hope that vitamin E might help prevent Alzheimer's disease, although in May a clinical trial of 769 patients with mild cognitive impairment found it was of no benefit in delaying the progression to Alzheimer's.

In that trial, the patients took a mega dose 2,000 IU a day for up to three years, according to the findings in the New England Journal of Medicine.

Other vitamin E / Alzheimer's trials are ongoing.

The anti-oxidant vitamin enthusiasm of the 1990s is being tempered by clinical trials, according to a JAMA editorial that accompanied the Women's Health Study results.

"These hopes are now confined to modest expectations for specific disorders and there are concerns about adverse effects," the editorial said.

Mike Freije from Health Shop
http://www.health-shop.com
http://www.health-shop.com

disinfecting cleaning services Glenview ...

In The News:

Educational Testing Service hackers stole millions of California student records, but families who moved out of state years ago may also be affected.

Apple's iPhone Duo screens are cracking near the hinge just days after its $1,999 launch, and iFixit's CT scans may reveal what's going wrong.

Travel expert Katy Nastro says 50,000 American Airlines AAdvantage miles vanished from her account after someone redeemed them without permission.

Google AI Overviews can't be permanently turned off, but adding -AI to your searches and using the built-in Web filter can help bypass AI summaries.

Attaxion researchers found 30 fake Texas campaign merchandise stores traced to just two sellers hawking gear for competing Republicans and Democrats.

GM plans to debut eyes-off driving in the Cadillac Escalade IQ by 2028, but safety testing reveals how long distracted drivers take to regain control.

Data brokers assign labels predicting your health, finances and religion based on browsing and purchases, then sell those profiles to businesses.

Elon Musk says he'll give one SpaceX share to every kid in America in 2027, but key details about eligibility and distribution remain unclear.

ClearSpace UK's robotic spacecraft with giant claws will chase down dead satellites at 17,000 mph, with a 2029 launch from Scotland planned.

A fake Social Security statement phishing email uses the SSA logo and a convincing layout, but the sender's domain instantly exposes the scam.

A clean credit report doesn't mean your identity is safe. Six ways criminals can steal from you without triggering a credit monitoring alert.

Carolyn Marvin, a 78-year-old retired professor, was arrested after blocking an Uber Eats delivery robot on a Philadelphia sidewalk for months.

The Midnight Mimosa malware campaign hides inside cheap Android phone firmware, giving attackers powerful access before owners even turn devices on.

The Fox News AI Newsletter covers the latest artificial intelligence technology advancements, including the challenges and opportunities AI presents now and for the future.

Meta's Muse AI was built to manage tasks, but users are developing romantic AI relationships and even calling the AI companion their girlfriend.

A Minnesota murder suspect's notebook listed 11 people search websites, raising urgent questions about data broker opt-out and online privacy risks.

Google Universal Cart tracks price drops, surfaces promo codes and uses Google Wallet to match your best credit card rewards before checkout.

Safari's Notify Me feature and Google's price-tracking tools can monitor products and send alerts when prices drop on your iPhone or Android.

George Weiner built PACspam.org to trace who sends nonstop political fundraising texts after blocking numbers repeatedly failed to stop the messages.

A dedicated VPN IP address may reduce frustrating CAPTCHAs and bank login security checks by giving websites a consistent connection to recognize.

Apple Wallet in iOS 27 lets you create digital passes from physical cards using a photo or screenshot, but not every card in your wallet qualifies.

Anthropic's Claude AI submitted a fabricated eyewitness tip about an unsolved murder to a Philadelphia police website during automated testing.

P7 DarkSword iPhone spyware can steal saved passwords, photos, Apple Notes and cryptocurrency wallet data by checking for commands every 15 seconds.

Cybersecurity experts told Fox News Digital that a cyberattack on French supermarket freezers should warn the U.S. about critical infrastructure gaps.

The Oracle Health breach exposed medical records, Social Security numbers and diagnoses of nearly 20 million patients across multiple states.

Reviving Vitamin E Studies That Challenge Claims of Wonder Supplement Also Leave Openings

Nutritional Supplements